Summary & Overview
Hernia Procedures Except Inguinal and Femoral without CC/MCC: Inpatient Reimbursement Overview
DRG 355 encompasses inpatient hernia procedures other than inguinal and femoral when no Major Complication or Comorbidity and no Complication or Comorbidity are present; it covers repairs like ventral and incisional hernias performed without significant additional diagnoses. This grouping matters for inpatient reimbursement because Diagnosis-Related Group assignment drives base Medicare payment and reflects expected resource use for routine hernia repair admissions.
DRG 355 Overview
DRG 355 covers noninguinal, nonfemoral hernia repair procedures for hospital inpatients when no Major Complication or Comorbidity and no Complication or Comorbidity are coded. This Diagnosis-Related Group groups cases by similar resource use for routine hernia repairs such as ventral or incisional hernias without significant comorbidity. It matters for Medicare inpatient reimbursement because grouping affects base payment, case mix, and hospital billing for surgical admissions. Accurate coding of principal procedure and any comorbid conditions determines assignment to this Diagnosis-Related Group and the associated payment.
Clinical Trials
- Trials comparing laparoscopic versus open repair techniques for non-inguinal, non-femoral hernias (such as ventral, incisional, or epigastric hernias) focusing on perioperative complication rates, operative time, and short-term resource utilization; these studies enroll adult surgical inpatients presenting for elective or urgent hernia repair and seek to define which approach minimizes length of stay and postoperative complications. This research is relevant to providers deciding operative strategy and to payers concerned with inpatient costs and readmissions tied to surgical approach.
- Comparative effectiveness studies evaluating mesh types and fixation methods (absorbable versus permanent mesh, and suture versus tack or adhesive fixation) in repair of non-inguinal abdominal wall hernias, measuring recurrence, wound infection, and need for reoperation over 1–3 years; these trials typically include patients with varying comorbidity burdens (obesity, diabetes, prior abdominal surgery) to determine which materials and techniques best reduce long-term failure. Findings inform surgical best practices that affect downstream costs from recurrent hernia repairs and chronic complications important to bundled payment models.
- Post-discharge outcomes and care-pathway research assessing enhanced recovery protocols, outpatient-to-inpatient transition, and patient-reported functional recovery after non-inguinal hernia repair, including monitoring of pain control, wound complications, and return to work over 30–90 days; studies may target older adults and patients with multiple comorbidities who are at higher risk for readmission. This area is important to providers and payers because optimizing discharge criteria and follow-up reduces avoidable inpatient utilization and supports more accurate reimbursement and quality measurement for this DRG.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.